Larimar Therapeutics Insider Purchase Boosts Stock 15.5%

Insider Purchase Triggers 15.5% Stock Surge

Larimar Therapeutics Inc (NASDAQ:LRMR) experienced a share price increase of approximately 15.5% on Thursday after a disclosed insider transaction. Director Thomas Edward Hamilton filed a Form 4 with the Securities and Exchange Commission indicating that he acquired 50,000 shares of the company’s common stock on Sunday. The acquisition was executed in multiple transactions at prices ranging from $3.33 to $3.35 per share, resulting in a weighted‑average purchase price of $3.3378 and a total outlay of roughly $166,890.

Following the purchase, Hamilton’s direct ownership rose to 714,798 shares. In addition, he holds an indirect stake of 159,433 shares through Post Edison, LLC. The sizable insider purchase is interpreted as a vote of confidence from a board member in the biopharmaceutical firm.